"Antineoplastic Agents/administration and dosage"[MeSH] - Search Results

Year	Number of Results
1957	2
1958	2
1964	5
1965	20
1966	57
1967	73
1968	111
1969	138
1970	160
1971	191
1972	179
1973	139
1974	160
1975	108
1976	111
1977	161
1978	334
1979	516
1980	561
1981	592
1982	764
1983	699
1984	353
1985	359
1986	333
1987	321
1988	283
1989	376
1990	357
1991	378
1992	372
1993	339
1994	466
1995	811
1996	1497
1997	1388
1998	1393
1999	1431
2000	1570
2001	1658
2002	1865
2003	2012
2004	2172
2005	2361
2006	2776
2007	2833
2008	2997
2009	3415
2010	3860
2011	3951
2012	4540
2013	4665
2014	4645
2015	5057
2016	4808
2017	4779
2018	4439
2019	4490
2020	4100
2021	2815
2022	407
2023	197
2024	2181
2025	8

1

Efficacy and Safety of Biosimilar Cetuximab Versus Innovator Cetuximab in Indian Patients With Head and Neck Cancer: A Multicenter, Randomized, Double-Blind, Phase III Trial.

Prabhash K, Deshmukh C, Malhotra H, Sharma A, Jain M, Dhamne N, Nagarakar R, Ganesan P, Mahobia VK, Das CK, Kumar R, Shivanna PS, Avaronnan MP, Chaithanya PK, Chaudhary V, Singh K, Aagre S, Ravishankar B, Mehta D, Shilpa K, Maniar V, Chatterjee K, Majumdar SD, Dana R, Noronha V, Menon N, Sharma A, Pawar R, Shahavi V, Yadav R, Aiwale A. Prabhash K, et al. JCO Glob Oncol. 2024 Nov;10:e2400059. doi: 10.1200/GO.24.00059. Epub 2024 Nov 14. JCO Glob Oncol. 2024. PMID: 39541562 Clinical Trial.

2

Hepatic arterial infusion chemotherapy combined with systemic therapy sequentially or simultaneously for advanced hepatocellular carcinoma.

Cao YZ, Pan JY, Zheng GL, An C, Zuo MX. Cao YZ, et al. Cancer Immunol Immunother. 2024 Nov 14;74(1):24. doi: 10.1007/s00262-024-03872-6. Cancer Immunol Immunother. 2024. PMID: 39540963

3

The role of single-dose prophylactic methotrexate in the prevention of post-molar gestational trophoblastic neoplasia in patients with high-risk molar pregnancy.

Akhavan S, Hoorshad N, Mousavi AS, Sheikhhasani S, Rezayof E, Zamani N. Akhavan S, et al. BMC Cancer. 2024 Nov 13;24(1):1400. doi: 10.1186/s12885-024-13162-0. BMC Cancer. 2024. PMID: 39538177 Free PMC article.

4

Interim analysis of the multinational, post-authorization safety study (NISSO) to assess the long-term safety of sonidegib in patients with locally advanced basal cell carcinoma.

Gutzmer R, Leiter U, Mohr P, Kähler KC, Ascierto PA, Scalvenzi M, Peris K, Pérez-Pastor GM, Fernández-de-Misa R, Botella-Estrada R, Hunger RE, Martelli S, Güneli N, Arntz R, Hauschild A. Gutzmer R, et al. BMC Cancer. 2024 Nov 14;24(1):1401. doi: 10.1186/s12885-024-13101-z. BMC Cancer. 2024. PMID: 39538176 Free PMC article.

5

Bioinspired intratumoral infusion port catheter improves local drug delivery in the liver.

Pedersoli F, Mohammad IS, Patel AK, Kessler J, Chao C, Liu B, Lall C, Guerra C, Park JJ, Boas FE. Pedersoli F, et al. Sci Rep. 2024 Nov 13;14(1):27782. doi: 10.1038/s41598-024-79694-4. Sci Rep. 2024. PMID: 39538011 Free PMC article.

6

Dose Modifications in the Management of Chronic Phase Chronic Myeloid Leukemia: Who, What, and When.

Oehler VG, Huang IJ, Siu C, Kim M, Signorelli J, Bell CS, Hobbs GS. Oehler VG, et al. J Natl Compr Canc Netw. 2024 Nov;22(9):e247044. doi: 10.6004/jnccn.2024.7044. J Natl Compr Canc Netw. 2024. PMID: 39536447 Review.

7

pH-Responsive Charge-Reversal Smart Nanoparticles for Co-Delivery of Mitoxantrone and Copper Ions to Enhance Breast Cancer Chemo-Chemodynamic Combination Therapy.

Tan T, Chang W, Wang TL, Chen W, Chen X, Yang C, Yang D. Tan T, et al. Int J Nanomedicine. 2024 Nov 7;19:11445-11462. doi: 10.2147/IJN.S479125. eCollection 2024. Int J Nanomedicine. 2024. PMID: 39530107 Free PMC article.

8

Ocular Pharmacodynamics of Intravitreal Faricimab in Patients With Neovascular Age-Related Macular Degeneration or Diabetic Macular Edema.

Diack C, Avery RL, Cheung CMG, Csaky KG, Gibiansky L, Jaminion F, Gibiansky E, Sickert D, Stoilov I, Cosson V, Bogman K. Diack C, et al. Transl Vis Sci Technol. 2024 Nov 4;13(11):13. doi: 10.1167/tvst.13.11.13. Transl Vis Sci Technol. 2024. PMID: 39535745 Free PMC article. Clinical Trial.

9

Ocular Pharmacokinetics of Faricimab Following Intravitreal Administration in Patients With Retinal Disease.

Diack C, Gibiansky L, Jaminion F, Gibiansky E, Gaudreault J, Bogman K, Cosson V. Diack C, et al. Transl Vis Sci Technol. 2024 Nov 4;13(11):14. doi: 10.1167/tvst.13.11.14. Transl Vis Sci Technol. 2024. PMID: 39535744 Free PMC article. Clinical Trial.

10

Low-dose apatinib in combination with chemotherapy for hormone receptor-positive, HER2-negative breast cancer with pulmonary lymphangitic carcinomatosis: A case report.

Chen L, Feng S, Chen X, Du C. Chen L, et al. Medicine (Baltimore). 2024 Nov 8;103(45):e40345. doi: 10.1097/MD.0000000000040345. Medicine (Baltimore). 2024. PMID: 39535586 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

84,642 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

84,642 results

Results by year